Phoenix Biotechnology Competitors and Similar CompaniesClear all
RAPT Therapeutics's competitors and similar companies include Xilio Therapeutics.
 RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. |  Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | |
Founding Date | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Waltham, US HQ |
Employees | Employees 64 | Employees 69 |
Valuation ($) | Valuation ($) 69.8 m | Valuation ($) 43.5 m |
Financial | ||
Net income | Net income ($129.9m) (FY, 2024) | Net income ($35m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 176m | Total funding raised $ 233m |
For sources of this data, please see the company profile
View Company Profiles
Xilio Therapeutics
HQ
Waltham, US
Employees
69
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View company